Dr Reddys Laboratories informs about disclosure

28 Jul 2021 Evaluate
Dr Reddys Laboratories has informed that the Company has filed its unaudited condensed consolidated interim financial statements prepared under IFRS in Form 6-K for the quarter ended June 30, 2021, with the United States Securities and Exchange Commission on July 27, 2021. A copy of the Form 6- K is attached.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1287.20 -31.70 (-2.40%)
27-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1738.10
Dr. Reddys Lab 1287.20
Cipla 1347.65
Zydus Lifesciences 922.50
Lupin 2301.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×